BioSpace News Archive

Centene Corporation announced that it has commenced an underwritten public offering to sell $1,800,000,000 of senior notes.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it was granted Breakthrough Therapy designation (BTD) by the U.S. Food and Drug Administration (FDA) for ARO-AAT, also known as TAK-999, the company’s second-generation investigational RNA interference (RNAi) therapeutic being co-developed with Takeda Pharmaceutical Company Limited (“Takeda”) as a treatment for the rare genetic liver disease associated with alpha-1 antitrypsin deficiency (AATD).

Bota Bio, a global industrial biotechnology company advancing sustainable biomanufacturing, announced that it has raised more than $100 million in an oversubscribed Series B funding round.

Daewoong Pharmaceutical announced its phase 2B clinical trial topline results for Foistar, which is being developed as a treatment for COVID-19.

Baylis Medical announced the first clinical use of the VersaCross® Large Access Solution.

West Pharmaceutical Services, Inc. announced its financial results for the second-quarter 2021 and updated full-year 2021 financial guidance.

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company, and Kumquat Biosciences announced an exclusive collaboration focused on the discovery, development and commercialization of potential novel small molecules that stimulate tumor-specific immune responses.

HanAll Biopharma announced that the company had achieved sales of 23.4 billion won, operating profit of 1.6 billion won, and net profit of 3.3 billion won in the second quarter of 2021.

Rockwell Medical, Inc. announced that it will host a conference call on Monday, August 16, 2021, at 4:30 p.m. ET to discuss its financial results for the three months ended June 30, 2021, and recent operational highlights.

Passage Bio, Inc., a clinical-stage genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, announced that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, August 5, 2021 to report its second quarter 2021 financial results and discuss recent business highlights.